These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 37932797)
21. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494 [TBL] [Abstract][Full Text] [Related]
22. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy. Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610 [TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients. Pedrotti P; Vittori C; Facchetti R; Pedretti S; Dellegrottaglie S; Milazzo A; Frigerio M; Cipriani M; Giannattasio C; Roghi A; Rimoldi O Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):130-137. PubMed ID: 27625368 [TBL] [Abstract][Full Text] [Related]
24. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096 [TBL] [Abstract][Full Text] [Related]
25. The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis. Hu M; Song Y; Yang C; Wang J; Zhu W; Kan A; Yang P; Dai J; Yu H; Gong L Sci Rep; 2024 Jul; 14(1):16832. PubMed ID: 39039146 [TBL] [Abstract][Full Text] [Related]
26. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study. Pöyhönen P; Kivistö S; Holmström M; Hänninen H BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650 [TBL] [Abstract][Full Text] [Related]
27. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes. Butler CR; Kumar A; Toma M; Thompson R; Chow K; Isaac D; Kim D; Haykowsky M; Friedrich MG; Paterson I Can J Cardiol; 2013 Sep; 29(9):1076-83. PubMed ID: 23380296 [TBL] [Abstract][Full Text] [Related]
28. Right ventricular insertion site fibrosis in a dilated cardiomyopathy referral population: phenotypic associations and value for the prediction of heart failure admission or death. Mikami Y; Cornhill A; Dykstra S; Satriano A; Hansen R; Flewitt J; Seib M; Rivest S; Sandonato R; Lydell CP; Howarth AG; Heydari B; Merchant N; Fine N; White JA J Cardiovasc Magn Reson; 2021 Jun; 23(1):79. PubMed ID: 34134712 [TBL] [Abstract][Full Text] [Related]
29. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy]. Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144 [TBL] [Abstract][Full Text] [Related]
30. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure. Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767 [TBL] [Abstract][Full Text] [Related]
31. Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging. Te Rijdt WP; Ten Sande JN; Gorter TM; van der Zwaag PA; van Rijsingen IA; Boekholdt SM; van Tintelen JP; van Haelst PL; Planken RN; de Boer RA; Suurmeijer AJH; van Veldhuisen DJ; Wilde AAM; Willems TP; van Dessel PFHM; van den Berg MP Eur Heart J Cardiovasc Imaging; 2019 Jan; 20(1):92-100. PubMed ID: 29635323 [TBL] [Abstract][Full Text] [Related]
32. Assessment of Left Ventricular Myocardial Fibrosis in Adult Patients With Ebstein Anomaly: A Retrospective Cohort Study Based on Cardiac Magnetic Resonance and Histopathological Samples. Fernandez-Badillo V; Serrano-Roman J; Antonio-Villa NE; Cabello-Ganem A; Espejel-Guzman A; Torres-Araujo LV; Aranda-Fraustro A; Cano-Zarate R; Solorzano-Pinot E; Keirns C; Meave-Gonzalez A; Alexanderson-Rosas E; Espinola-Zavaleta N Circ Cardiovasc Imaging; 2023 May; 16(5):e015011. PubMed ID: 37154028 [TBL] [Abstract][Full Text] [Related]
33. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure. Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712 [TBL] [Abstract][Full Text] [Related]
34. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy. Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM; J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243 [TBL] [Abstract][Full Text] [Related]
35. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction. Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142 [TBL] [Abstract][Full Text] [Related]
37. Diffusely Increased Myocardial Extracellular Volume With or Without Focal Late Gadolinium Enhancement: Prevalence and Associations With Left Ventricular Size and Function. Lundin M; Sörensson P; Maret E; Jenner J; Abdula G; Nickander J; Themudo R; Caidahl K; Kellman P; Sigfridsson A; Ugander M J Thorac Imaging; 2022 Jan; 37(1):17-25. PubMed ID: 32271280 [TBL] [Abstract][Full Text] [Related]
38. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients. Florian A; Ludwig A; Engelen M; Waltenberger J; Rösch S; Sechtem U; Yilmaz A J Cardiovasc Magn Reson; 2014 Sep; 16(1):81. PubMed ID: 25315351 [TBL] [Abstract][Full Text] [Related]
39. Left ventricular myocardial strain responding to chronic pressure overload in patients with resistant hypertension evaluated by feature-tracking CMR. Chen H; Brunner FJ; Özden C; Wenzel UO; Neumann JT; Erley J; Saering D; Muellerleile K; Maas KJ; Schoennagel BP; Cavus E; Schneider JN; Blankenberg S; Koops A; Adam G; Tahir E Eur Radiol; 2023 Sep; 33(9):6278-6289. PubMed ID: 37032365 [TBL] [Abstract][Full Text] [Related]
40. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy. Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]